Netherlands· NL-6c9e7905b26d

Zonegran 50 mg, orodispergeerbare tablet

A zonisamide product containing zonisamide, registered in Netherlands by Amdipharm Limited. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX15

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about zonisamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Zonisamide is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX15 (zonisamide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search zonisamide products by name

Zonisamide · ATC N03AX15

18 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zonisamide costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.78 in United States to $10.28 in Switzerland — a ×13 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Zonisamide · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$10.28
IT Italy$2.90
FR France$1.20
US United States$0.78 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ZONISAMIDE
Manufacturer: Amdipharm Limited
Country: Netherlands (NL)
ATC code: N03AX15
ATC class: Zonisamide
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/04/307

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

239 interactions on record for zonisamide.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check zonisamide against other medicines How interaction checks work

Zonisamide · interactions on record

239 records

43 severe
105 moderate
66 info

Most severe, free to view

DicycloverineA03AA07severe
PropanthelineA03AB05severe
MepenzolateA03AB12severe
TrospiumA03AB20severe

25 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zonisamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zonisamide products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Zonisamid Aristo
Bulgaria · Зокап
Czechia · Ersittin, Zonisamid Sandoz
Germany · Zonisamid 1 A Pharma, Zonisamid Accord
Denmark · Zonisamid Desitin, Zonisamid Glenmark
Estonia · Zonisamide Sandoz
Spain · Nyzol, Zonesme
Finland · Zonisamide Desitin
France · Zonisamide Arrow, Zonisamide Neuraxpharm
United Kingdom (Northern Ireland) · Desizon, Zonisamide Accord
Croatia · Zocap
Ireland · Zonisamide Desitin, Zonisamide Rowex
Iceland · Zonegran, Zonisamide Viatris
Italy · Zonisamide Doc Generici, Zonisamide Sandoz
Liechtenstein · Zonegran, Zonisamide Viatris
Lithuania · Zonisamide Sandoz
Malta · Zonisamide Doc Generici
Norway · Zonegran, Zonisamid Desitin
Poland · Zonisamidum Neuraxpharm
Portugal · Zonisamida Aristo, Zonisamida Generis
Romania · Zocap, Zonisamidă Desitin
Sweden · Zonisamide 1a Farma
Slovenia · Zocap, Zonisamid Sandoz
Slovakia · Zonisamide Neuraxpharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bb225398-1fb0-4541-aaba-ce4608641d77
GET /v1/drugs/bb225398-1fb0-4541-aaba-ce4608641d77?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Orodispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zonegran-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Zonisamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp104985",
  "excipients": [
    "ASPARTAAM (E 951)",
    "BENZYLALCOHOL (E 1519)",
    "GELATINE, AFKOMSTIG VAN VIS",
    "LIMONEEN (VORM ONBEKEND)",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "SINAASAPPELSMAAKSTOF 501071 AP0551 Firmenich",
    "TOCOFEROL, ALFA (OPTISCHE ROTATIE ONBEKEND)"
  ],
  "substances": [
    "ZONISAMIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2010/07/27",
  "procedure_number": "EMEA/H/C/000577",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/04/307",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about zonisamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console